Cargando…
Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer
PURPOSE: Mutation-specific T-cell response to epithelial cancers and T-cell-based immunotherapy has been successfully used to treat several human solid cancers. We aimed to investigate the anti-tumour effect of neo-antigen-reactive T(NRT) cells induced by RNA mutanome vaccine, which may serve as a f...
Autores principales: | Sun, Jiaxing, Zhang, Jing, Hu, Haiyan, Qin, Huan, Liao, Ximing, Wang, Feilong, Zhang, Wei, Yin, Qi, Su, Xiaoping, He, Yanan, Li, Wenfeng, Wang, Kun, Li, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484245/ https://www.ncbi.nlm.nih.gov/pubmed/34291357 http://dx.doi.org/10.1007/s00432-021-03735-y |
Ejemplares similares
-
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer
por: McCann, Katy, et al.
Publicado: (2022) -
Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012) -
Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer
por: Qin, Huan, et al.
Publicado: (2023) -
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
por: Overwijk, Willem W, et al.
Publicado: (2013) -
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
por: Vormehr, Mathias, et al.
Publicado: (2015)